#1 Clinical Trials Search in Europe

Cyanocobalamin

This article examines various clinical trials investigating the use of cyanocobalamin, also known as vitamin B12, in medical treatments. These studies explore cyanocobalamin’s effects on vitamin B12 deficiency, absorption, and potential benefits in conditions like septic shock and vasoplegic syndrome. The trials aim to optimize dosing methods, compare oral and intramuscular administration, and assess cyanocobalamin’s impact on health outcomes in different patient populations.

Table of Contents

What is Cyanocobalamin?

Cyanocobalamin is a synthetic form of vitamin B12, an essential nutrient that plays a crucial role in many bodily functions. It is also known by other names such as cobalamin, B12, and Eligen B12[1]. Vitamin B12 is important for the production of red blood cells and the proper functioning of the nervous system[2].

Uses and Benefits

Cyanocobalamin is primarily used to treat or prevent vitamin B12 deficiency. This deficiency can lead to various health issues, including:

  • Anemia: A condition where there are not enough healthy red blood cells to carry oxygen to tissues[2].
  • Neurological problems: Vitamin B12 is crucial for maintaining a healthy nervous system[2].
  • Fatigue and weakness: Common symptoms of vitamin B12 deficiency[2].

Some studies have also explored the potential benefits of cyanocobalamin in other areas:

  • Improving voice performance in singers: Some research has investigated whether vitamin B12 treatment can enhance vocal performance[3].
  • Treating vasoplegic syndrome: A condition that can occur after heart surgery, characterized by low blood pressure. High doses of vitamin B12 (in the form of hydroxocobalamin) are being studied as a potential treatment[4][5].

Forms and Administration

Cyanocobalamin can be administered in several ways:

  • Oral tablets: Taken by mouth, often used for maintenance therapy[1].
  • Intramuscular (IM) injections: Injected into a muscle, often used for initial treatment of deficiency[6].
  • Intravenous (IV) injections: Injected directly into a vein, used in some clinical settings[1].

The dosage and form of administration depend on the specific condition being treated and the severity of the deficiency. Always follow your healthcare provider’s instructions regarding dosage and administration.

Research and Clinical Trials

Several clinical trials have been conducted or are ongoing to investigate various aspects of cyanocobalamin treatment:

  • Oral vs. Intramuscular Administration: Studies are comparing the effectiveness of oral cyanocobalamin tablets to intramuscular injections in treating vitamin B12 deficiency[6].
  • Impact on Anemia Treatment: Research is exploring how vitamin B12 supplementation might affect the dosing of other anemia treatments (like Epogen) in hemodialysis patients[2].
  • High-Dose Treatment for Vasoplegic Syndrome: Clinical trials are investigating the use of high doses of hydroxocobalamin (a form of vitamin B12) for treating low blood pressure after heart surgery[4][5].
  • Effects on Voice Performance: Some studies are looking into whether vitamin B12 treatment can improve vocal performance in singers[3].

Potential Side Effects

While cyanocobalamin is generally considered safe, some potential side effects may occur:

  • Skin reactions: Such as itching or rash.
  • Gastrointestinal issues: Like diarrhea or upset stomach.
  • Headache
  • Dizziness

In high doses, as used in some clinical trials for vasoplegic syndrome, vitamin B12 can cause a red discoloration of the skin and urine. This is harmless and temporary[7].

It’s important to note that serious allergic reactions to cyanocobalamin are rare. However, you should seek immediate medical attention if you experience symptoms of a severe allergic reaction, such as difficulty breathing, severe dizziness, or swelling of the face, lips, tongue, or throat.

Study Focus Administration Method Key Outcomes Measured Patient Population
Bioavailability comparison Oral vs. Intravenous Pharmacokinetics, Safety, Tolerability Healthy male subjects
Effects on singers’ voice Intramuscular injection Voice performance, Mental wellbeing Singers
Impact on Epogen dosing in hemodialysis Intramuscular injection Epogen requirements, Quality of life Hemodialysis patients
Oral vs. Intramuscular for B12 deficiency Oral and Intramuscular B12 level normalization, Adverse events Elderly patients (≥65 years)
High-dose treatment in septic shock Intravenous infusion Hydrogen sulfide levels, Vasopressor requirements Septic shock patients

FAQ

  • What is cyanocobalamin? Cyanocobalamin is a synthetic form of vitamin B12, an essential nutrient that plays a crucial role in red blood cell formation, neurological function, and DNA synthesis. It is commonly used to treat or prevent vitamin B12 deficiency.
  • How is cyanocobalamin administered in these clinical trials? The trials explore various administration methods, including oral tablets, intramuscular injections, and intravenous infusions. Some studies compare the effectiveness of different routes of administration.
  • What conditions are being studied in relation to cyanocobalamin treatment? The clinical trials investigate cyanocobalamin's effects on vitamin B12 deficiency, anemia in hemodialysis patients, septic shock, vasoplegic syndrome in cardiac surgery patients, and its potential impact on singers' voice performance.
  • Are there any potential side effects of cyanocobalamin treatment? While cyanocobalamin is generally considered safe, some trials monitor for adverse events. One study notes that high-dose intravenous administration may cause a red coloration of urine, which is harmless but noticeable.
  • How might cyanocobalamin treatment benefit patients? Potential benefits being studied include improved vitamin B12 levels, reduced anemia, better quality of life for hemodialysis patients, enhanced voice performance in singers, and improved outcomes in septic shock and vasoplegic syndrome patients. However, these benefits are still being researched and are not yet conclusively proven.

Ongoing Clinical Trials on Cyanocobalamin

  • Study on Faster Weaning from Ventilators in Critically Ill Patients Using Levosimendan and a Drug Combination

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Tricortin 1000, Diclofenac Sodium, and Paracetamol for Patients with Chronic Low Back Pain

    Recruiting

    1 1 1
    Investigated drugs:
    Italy

  • Study on the Early Use of Levosimendan Compared to Placebo for Patients with Cardiogenic Shock

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on the Effectiveness of Calcium Folinate, Omega-3-Acid Ethyl Esters, and Cyanocobalamin for Patients at High Risk of Psychosis or Experiencing First Episode Psychosis

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Cyanocobalamin: A synthetic form of vitamin B12 used to treat or prevent vitamin B12 deficiency. It is essential for red blood cell formation, neurological function, and DNA synthesis.
  • Cobalamin: Another name for vitamin B12, which includes various forms such as cyanocobalamin and hydroxocobalamin.
  • Holotranscobalamin: The biologically active form of vitamin B12 in the blood, used as a marker for vitamin B12 status.
  • Methylmalonic acid (MMA): A substance that can be measured in the blood to help diagnose vitamin B12 deficiency, especially when B12 levels are borderline.
  • Erythropoietin (Epogen): A hormone that stimulates red blood cell production, often used to treat anemia in patients with kidney disease.
  • Vasoplegic syndrome: A condition characterized by low blood pressure and decreased responsiveness to vasopressor medications, often occurring after cardiac surgery.
  • Septic shock: A life-threatening condition caused by a severe infection leading to dangerously low blood pressure and organ failure.
  • Pharmacokinetics (PK): The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Bioavailability: The proportion of a drug or substance that enters the circulation when introduced into the body and is able to have an active effect.
  • Intramuscular (IM): A method of administering medication by injection into a muscle.

References

  1. https://clinicaltrials.gov/study/NCT01311739
  2. https://clinicaltrials.gov/study/NCT01876732
  3. https://clinicaltrials.gov/study/NCT03437824
  4. https://clinicaltrials.gov/study/NCT03735316
  5. https://clinicaltrials.gov/study/NCT06160219
  6. https://clinicaltrials.gov/study/NCT01476007
  7. https://clinicaltrials.gov/study/NCT03783091